Physician profile
Michael A Robinson
NPI 1366430803
$22,915.59
in general payments reported to CMS, 2019-2025
16 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,155 · 2020: $427 · 2021: $1,775 · 2022: $3,541 · 2023: $2,833 · 2024: $12K · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $3,194 · Food and Beverage: $2,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,427.50 |
| Travel and Lodging | $3,194.31 |
| Food and Beverage | $2,396.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $11,501.32 | 2024 | Djo Surgical |
| Stryker Corporation | $4,682.92 | 2019-2025 | Mako |
| Smith+Nephew, INC. | $3,201.49 | 2019-2025 | Real Intelligence, Ri Hip Navigation, Journey |
| Lima USA, INC. | $2,366.26 | 2021-2023 | Lantern Surgical Assistant |
| Davol INC. | $505.22 | 2022-2025 | Arista |
| Balt USA, LLC | $180.03 | 2024 | Optima Coil System |
| Depuy Synthes Sales INC. | $172.64 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $117.23 | 2021-2022 | |
| Medical Device Business Services, INC. | $47.19 | 2025 | Velys |
| Heron Therapeutics, INC. | $39.58 | 2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $21.32 | 2021 | |
| Team 1, LLC | $21.28 | 2024 | |
| Ethicon US, LLC | $16.97 | 2025 | Stratafix |
| Innovation Technologies INC | $15.05 | 2025 | Irrisept |
| Arteriocyte Medical Systems, INC. | $14.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.